Evogene EVGN
NASDAQ EVGN
$0.56 +0.00 (+0.36%)
At close: Aug 21, 2026 · 4:00 PM EDT

Evogene (EVGN) Profit After Tax (2012 - 2026)

Evogene (EVGN) posted Profit After Tax of $5.9 million for Q1 2026, up 210.12% sequentially from -$5.4 million in Q4 2025, and up 97.26% YoY from $3.0 million in Q1 2025.

Evogene (EVGN) Profit After Tax (2012 - 2026) Analysis & Trends

Evogene has reported Profit After Tax for 15 years, with the latest figure at $5.9 million in Q1 2026.

  • Quarterly Profit After Tax rose 97.26% year-over-year to $5.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.4 million (up 192.95% YoY) and the FY2025 annual result came in at -$7.8 million, up 56.65% from the prior year.
  • Profit After Tax improved to $5.9 million in Q1 2026 per EVGN's latest filing, from -$5.4 million in the prior quarter.
  • Over five years, Profit After Tax peaked at $9.8 million in Q2 2022 and troughed at -$9.1 million in Q1 2022.
  • A 5-year average of -$590411.8 and a median of $5000.0 in 2024 frame the typical range for Profit After Tax.
  • The widest YoY moves for Profit After Tax: up 178.21% in 2025, down 107180.0% in 2025.
  • Over 5 years, Profit After Tax stood at $3.8 million in 2022, then tumbled by 292.02% to -$7.3 million in 2023, then surged by 100.07% to $5000.0 in 2024, then sank by 107180.0% to -$5.4 million in 2025, then surged by 210.12% to $5.9 million in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods registered $5.9 million, -$5.4 million, and $5.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -355.03 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -16.62 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 Evogene 4.38 Mn 4.38 Mn 204,000.00 5.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.90 Mn
Dec 31, 2025 -5.35 Mn
Sep 30, 2025 5.20 Mn
Jun 30, 2025 4.68 Mn
Mar 31, 2025 2.99 Mn
Dec 31, 2024 5,000.00
Sep 30, 2024 -8.22 Mn
Jun 30, 2024 -5.99 Mn
Mar 31, 2024 3.85 Mn
Dec 31, 2023 -7.34 Mn
Sep 30, 2023 -3.86 Mn
Jun 30, 2023 7.78 Mn
Mar 31, 2023 -6.98 Mn
Dec 31, 2022 3.82 Mn
Sep 30, 2022 -7.16 Mn
Jun 30, 2022 9.75 Mn
Mar 31, 2022 -9.11 Mn
Dec 31, 2021 8.08 Mn
Sep 30, 2021 8.34 Mn
Jun 30, 2021 6.90 Mn